documents: FDA-2021-N-0862-0206
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-0862-0206 | FDA | FDA-2021-N-0862 | TAB C-NSURE-ProposedRule-Final RE Memorandum - Nonprescription Drug Product With an Additional Condition for Nonprescription Use (Proposed Rule); Publication Date: June 28, 2022 | Supporting & Related Material | Background Material | 2023-01-20T05:00:00Z | 2023 | 1 | 2023-01-20T20:02:50Z | 0 | 0 | 09000064855fd2fe |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref